BioAge Labs (BIOA) Total Current Liabilities (2023 - 2026)
BioAge Labs (BIOA) posted Total Current Liabilities of $15.8 million for Q1 2026, down 21.41% sequentially from $20.1 million in Q4 2025, and down 33.33% YoY from $23.7 million in Q1 2025.
BioAge Labs (BIOA) Total Current Liabilities (2023 - 2026) Analysis & Trends
BioAge Labs has reported Total Current Liabilities for 4 years, with the latest figure at $15.8 million in Q1 2026.
- Quarterly Total Current Liabilities fell 33.33% year-over-year to $15.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.8 million (down 33.33% YoY) and the FY2025 annual result came in at $20.1 million, down 27.5% from the prior year.
- Total Current Liabilities retreated to $15.8 million in Q1 2026 per BIOA's latest filing, from $20.1 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $58.2 million in Q4 2023 and troughed at $15.8 million in Q1 2026.
- A 4-year average of $26.5 million and a median of $23.3 million in 2025 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities sank 52.25% in 2024, then gained 28.37% in 2025.
- Over 4 years, Total Current Liabilities stood at $58.2 million in 2023, then tumbled by 52.25% to $27.8 million in 2024, then dropped by 27.5% to $20.1 million in 2025, then declined by 21.41% to $15.8 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $15.8 million, $20.1 million, and $24.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | BioAge Labs | 436.28 Mn | 436.28 Mn | -14.23 Mn | 19.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.22 Mn |
| Mar 31, 2026 | 15.83 Mn |
| Dec 31, 2025 | 20.14 Mn |
| Sep 30, 2025 | 24.49 Mn |
| Jun 30, 2025 | 22.84 Mn |
| Mar 31, 2025 | 23.74 Mn |
| Dec 31, 2024 | 27.78 Mn |
| Sep 30, 2024 | 19.08 Mn |
| Dec 31, 2023 | 58.17 Mn |